Dr. Robert Wells, M.D

NPI: 1164536207
Total Payments
$268.96
2024 Payments
$91.52
Companies
6
Transactions
13
Medicare Patients
357
Medicare Billing
$15,999

Payment Breakdown by Category

Food & Beverage$268.96 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $268.96 13 100.0%

Top Paying Companies

Company Total Records Latest Year
Salix Pharmaceuticals, a division of Bausch Health US, LLC $114.36 6 $0 (2024)
Roche Diagnostics Corporation $89.43 3 $0 (2024)
Pharmacyclics LLC, An AbbVie Company $19.14 1 $0 (2021)
AstraZeneca Pharmaceuticals LP $16.32 1 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $16.16 1 $0 (2024)
Shionogi Inc $13.55 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $91.52 5 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($39.13)
2021 $75.06 4 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($55.92)
2020 $38.40 2 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($19.31)
2019 $50.43 1 Roche Diagnostics Corporation ($50.43)
2018 $13.55 1 Shionogi Inc ($13.55)

All Payment Transactions

13 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/02/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $16.16 General
Category: INTERNAL MEDICINE
07/17/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.65 General
Category: Gastroenterology
06/13/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $16.32 General
06/06/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.48 General
Category: Gastroenterology
03/27/2024 Roche Diagnostics Corporation BenchMark ULTRA (Device) Food and Beverage In-kind items and services $19.91 General
Category: Tissue Diagnostics
12/22/2021 Pharmacyclics LLC, An AbbVie Company IMBRUVICA (Drug) Food and Beverage In-kind items and services $19.14 General
Category: ONCOLOGY
08/12/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.50 General
Category: Gastroenterology
07/07/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.41 General
Category: Gastroenterology
02/22/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $16.01 General
Category: Gastroenterology
11/04/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.31 General
Category: GASTROENTEROLOGY
03/11/2020 Roche Diagnostics Corporation Food and Beverage In-kind items and services $19.09 General
11/07/2019 Roche Diagnostics Corporation DIS Navify Software (Device) Food and Beverage In-kind items and services $50.43 General
Category: Diagnostic Information Solutions
10/02/2018 Shionogi Inc Symproic (Drug) Food and Beverage In-kind items and services $13.55 General
Category: Gastroenterology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 302 422 $112,545 $11,749
2022 1 17 29 $5,626 $1,351
2021 1 20 29 $5,626 $1,421
2020 1 18 29 $5,626 $1,478
Total Patients
357
Total Services
509
Medicare Billing
$15,999
Procedure Codes
6

All Medicare Procedures & Services

6 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2023 231 338 $97,446 $9,144 9.4%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2023 58 65 $11,413 $1,714 15.0%
88331 Pathology examination of specimen during surgery, first tissue block Facility 2023 13 19 $3,686 $891.20 24.2%
88331 Pathology examination of specimen during surgery, first tissue block Facility 2022 17 29 $5,626 $1,351 24.0%
88331 Pathology examination of specimen during surgery, first tissue block Facility 2021 20 29 $5,626 $1,421 25.3%
88331 Pathology examination of tissue during surgery Facility 2020 18 29 $5,626 $1,478 26.3%

About Dr. Robert Wells, M.D

Dr. Robert Wells, M.D is a Anatomic Pathology & Clinical Pathology healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164536207.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Wells, M.D has received a total of $268.96 in payments from pharmaceutical and medical device companies, with $91.52 received in 2024. These payments were reported across 13 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($268.96).

As a Medicare-enrolled provider, Wells has provided services to 357 Medicare beneficiaries, totaling 509 services with total Medicare billing of $15,999. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.

Practice Information

  • Specialty Anatomic Pathology & Clinical Pathology
  • Location Irving, TX
  • Active Since 08/18/2006
  • Last Updated 06/10/2024
  • Taxonomy Code 207ZP0102X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1164536207

Products in Payments

  • XIFAXAN (Drug) $114.36
  • DIS Navify Software (Device) $50.43
  • BenchMark ULTRA (Device) $19.91
  • IMBRUVICA (Drug) $19.14
  • EOHILIA (Drug) $16.16
  • Symproic (Drug) $13.55

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology & Clinical Pathology Doctors in Irving